Ludwig, Wolf-Dieter

Seminar Title: 

SPD2 - Medicines for every disease – return on investment vs unmet clinical needs (25th Anniversary EAHP Congress - Hospital Pharmacy 5.0 - the future of patient care (2021))


Drug Commission of the German Medical Association



Current Status, Position

Prof Dr med Wolf-Dieter Ludwig has been the Chairman of the Drug Commission of the German Medical Association and a Co-Editor of "DER ARZNEIMITTELBRIEF" (ISDB) since 2006. He also is a Member of the Management Board of the European Medicines Agency as representative of the European Doctor's Association since 2013. From 2001 to August 2017, he was the Medical Director and Head of the Department for Haematology, Oncology, Tumour Immunology and Palliative Care at the HELIOS Clinic Berlin-Buch (formerly Charité).


Prof Dr med Ludwig studied medicine at the universities of Louvain, Innsbruck and Berlin. He got his Master Degree and PhD from the Free University of Berlin, with Degrees for specialisation in internal medicine, transfusion medicine and haematology/oncology.

Research Area

Prof Dr med Ludwig's research focuses on malignant hematologic disorders, precision medicine in oncology, regulatory science regarding approval of new drugs and postmarketing trials, independent drug information.

Conflict of interest: none